41 QUESTION WHAT SYSTEMIC CONDITIONS ARE ASSOCIATED WITH AN INCREASED RISK OF RETINAL DETACHMENT? WHAT SHOULD I DO ABOUT IT? Joseph N. Martel, MDMallika Doss, MD The risk of rhegmatogenous…
37 QUESTION WHAT SHOULD I TELL A PATIENT WITH RETINITIS PIGMENTOSA ABOUT PROGNOSIS AND SHOULD I PRESCRIBE VITAMIN A OR OTHER SUPPLEMENTS? Jackson Abou Chehade, MDRaymond Iezzi, MD, MS Retinitis…
36 QUESTION WHEN SHOULD CATARACT SURGERY BE PERFORMED IF A VITRECTOMY IS PLANNED—BEFORE, DURING, OR AFTER? Michael I. Seider, MDAmar Patel, MD There are many factors to consider when deciding…
22 QUESTION HOW DO I WORK UP AND MANAGE A PATIENT WITH A VITREOUS HEMORRHAGE? Pauline T. Merrill, MDMarina Gilca, MD When evaluating a patient with a vitreous hemorrhage, the…
16 QUESTION HOW DO I DIFFERENTIATE ALL OF THOSE WHITE DOT SYNDROMES? Arthi Venkat, MDSunil K. Srivastava, MD Although seeing a patient with a white dot syndrome can be intimidating…
15 QUESTION HOW SOON SHOULD A PATIENT WITH FLOATERS BE EXAMINED AND HOW SHOULD I MANAGE A PATIENT WITH AN ACUTE POSTERIOR VITREOUS DETACHMENT? Karen M. Gehrs, MD Floaters are…
12 QUESTION WHAT TYPE OF INTRAOCULAR LENS SHOULD BE CONSIDERED IN AN EYE WITH VITREORETINAL DISEASE? Marina Gilca, MDKourous A. Rezaei, MD It is well-documented that vitreous surgery leads to…
1 QUESTION WHAT IS HEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS, AND WHY DO I NEED TO KNOW ABOUT IT? James A. Stefater MD, PhDDean Eliott, MD Hemorrhagic occlusive retinal vasculitis (HORV) is…
2 QUESTION HOW DO I COUNSEL MY PATIENTS WITH DRY AGE-RELATED MACULAR DEGENERATION AND WHAT ABOUT VARIOUS VITAMIN SUPPLEMENTS? T. Y. Alvin Liu, MDCatherine B. Meyerle, MD Let us first…
6 QUESTION ARE WE EVER GOING TO USE STEM CELLS? FOR WHAT? WHAT’S THE SCOOP? Steven D. Schwartz, MD Progress in the diagnosis and treatment of retinal disease is advancing…
